InvestorsObserver is giving Corbus Pharmaceuticals Holdings Inc (CRBP) an Analyst Rating Rank of 16, meaning CRBP is ranked higher by analysts than 16% of stocks. The average price target for CRBP is $1.84 and analyst’s rate the stock as a Buy
Why are Analyst Ratings Important?
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With Corbus Pharmaceuticals Holdings Inc Stock Today?
Corbus Pharmaceuticals Holdings Inc (CRBP) stock is up 8.75% while the S&P 500 is down -0.07% as of 12:02 PM on Tuesday, Feb 9. CRBP is higher by $0.25 from the previous closing price of $2.80 on volume of 27,832,565 shares. Over the past year the S&P 500 has gained 16.73% while CRBP is down -51.51%. CRBP lost -$1.78 per share the over the last 12 months.